Search Tips

KMT2D suppresses Sonic Hedgehog-driven medulloblastoma progression and metastasis [RNA-seq]

UID: 11004

Description
Summary from GEO:

"The major cause for treatment failure, morbidity and mortality amongst medulloblastoma patients is metastasis intracranially or along the spinal cord. The molecular mechanisms driving tumor metastasis in SHH-driven medulloblastoma (SHH-MB) patients remain largely unknown. In this study we used mouse models of SHH-MB to define a tumor suppressive role of KMT2D (MLL4), a gene frequently mutated in the most metastatic β-subtype. Strikingly, heterozygous loss of Kmt2d in conjunction with aberrant activation of the SHH pathway causes highly penetrant disease with decreased survival, hindbrain invasion and spinal cord metastasis. Loss of Kmt2d shifts the transcriptional and chromatin landscape of primary and metastatic tumor cells to preferentially upregulate pathways and genes associated with advanced stage cancer and metastasis including TGFβ, Notch, Atoh1, Sox2/9 and Myc. Our study provides strong evidence that secondary mutations in KMT2D will have prognostic value for identifying SHH-MB patients that are likely to develop metastasis."

Overall design from GEO:

"RNA-seq of a mouse model of Sonic Hedgehog-driven medulloblastoma."
Subject of Study
Subject(s)
OncoTree Cancer Type(s)
Medulloblastoma
Access via GEO


Accession #: GSE210990

Access via BioProject


Accession #: PRJNA868709

Access Restrictions
Free to All
Access Instructions
The NCBI Gene Expression Omnibus and BioProject databases provide open access to these files.
Associated Publications
Equipment Used
Illumina HiSeq 2500
Dataset Format(s)
TXT
Dataset Size
796.5 KB
Data Catalog Record Updated
2023-11-06